BridgeBio Pharma’s Strategic Advancements and Promising Prospects Drive Buy Recommendation
Leerink Partners analyst Mani Foroohar maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) on November 12 and set a ...
Leerink Partners Sticks to Their Hold Rating for CureVac (CVAC)
Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company’s ...